PharmaPulse Podcast - Ep. 5: Why AstraZeneca UK has banned the word ‘omnichannel’, with Andrew Binns
Apr 2, 2024
In this episode we speak with Andrew Binns, Head of Digital Innovation at AstraZeneca, who discusses creating content to differentiate your brand, putting the customer at the heart of your strategy, and why the term ‘omnichannel’ is banned at AstraZeneca UK. Listen to the audio above, or watch on YouTube here:
For more insights around customer engagement, join us Reuters Events: Pharma 2024 (April 16-18, Barcelona), where 1,200 of the world's leading pharma changemakers are gathering under one roof. View the speakers and agenda here.